IP Verse

Aerosol Formulation For The Inhalation Of Beta Agonists - EP1940349B1

PatentPatent Analysis

EP1940349

BOEHRINGER INGELHEIM
Application Number
EP06807028A
Filing Date
Oct 6, 2006
Status
Opposition Rejected
Jul 10, 2020
Grant Date
Feb 14, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2488145B1
EP3150200B1
EP2395968B1

Bibliography

The patent EP1940349B1 was granted to Boehringer Ingelheim on Feb 14, 2018 following the initial filing on Oct 6, 2006 under the application number EP06807028A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSNov 13, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents